[Therapeutic use of a peptide fraction derived from bovine factor VIII in epistaxis in children].
The results obtained in patients suffering from essential epistaxis in paediatric age using a peptide fraction derived from the enzymatic hydrolysis of bovine factor VIII (VUEFFE-Baldacci) are reported. Carbazochrome sodium sulphate was employed for comparison purposes. Vueffe is effective in reducing haemorrhagic episodes without modifying the laboratory parameters investigated.
Tarantino
V
V
Stura
M
M
Cingolani
M
M
D000293:Adolescent; D000323:Adrenochrome / Q000031:analogs & derivatives / Q000627:therapeutic use; D002648:Child; D004341:Drug Evaluation; D004844:Epistaxis / Q000188:drug therapy*; D005169:Factor VIII / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D016032:Randomized Controlled Trials as Topic
D000323:Adrenochrome; C073338:carbazochrome; D005169:Factor VIII
Utilizzaione terapeutica di una frazione peptidica derivata dal fattore VIII bovino nelle epistassi in età pediatrica.